Skip to main content

Animations

MJFF Publications

7031 - 7040 of 8654 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100712
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-023-06566-w
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02616-7
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/dad2.12589
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Deep learning‐based BMI inference from structural brain MRI reflects brain alterations following lifestyle intervention
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26595
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29306
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Why Therapeutic Trials Fail in Primary Tauopathies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29322
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29353
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29358
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.